Renaissance Technologies - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 94 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$2,048,000
+1.7%
3,368,052
+9.4%
0.00%0.0%
Q1 2017$2,013,000
+163.8%
3,077,652
+24.4%
0.00%
+200.0%
Q4 2016$763,000
-28.0%
2,473,846
+0.5%
0.00%
-50.0%
Q3 2016$1,059,000
+115.2%
2,462,446
+82.3%
0.00%
+100.0%
Q2 2016$492,000
-6.8%
1,350,952
+7.7%
0.00%0.0%
Q1 2016$528,000
-67.6%
1,254,752
-10.0%
0.00%
-75.0%
Q4 2015$1,632,000
+574.4%
1,394,722
+488.1%
0.00%
+300.0%
Q3 2015$242,000
-87.3%
237,152
-83.7%
0.00%
-75.0%
Q2 2015$1,910,000
+1347.0%
1,458,251
+1429.9%
0.00%
Q4 2013$132,00095,3190.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 245,000$287,0000.41%
Iguana Healthcare Management, LLC 500,000$585,0000.19%
Sterling Global Strategies LLC 10,000$12,0000.19%
Delaney Dennis R 60,000$70,0000.16%
Freedom Investment Management, Inc. 816,347$955,0000.07%
BAXTER BROS INC 135,506$159,0000.06%
First Heartland Consultants, Inc. 86,204$101,0000.04%
TWO SIGMA SECURITIES, LLC 16,191$19,0000.02%
CORRADO ADVISORS, LLC 15,000$18,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 368,830$432,0000.01%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders